Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Unusual cardiovascular complications of brucellosis presenting in two men: two case reports and a review of the literature

  • Nikolaos K Gatselis1,
  • Konstantinos P Makaritsis1,
  • Ioannis Gabranis2,
  • Aggelos Stefos1,
  • Konstantinos Karanikas2 and
  • George N Dalekos1Email author
Journal of Medical Case Reports20115:22

https://doi.org/10.1186/1752-1947-5-22

Received: 6 April 2010

Accepted: 20 January 2011

Published: 20 January 2011

Abstract

Introduction

Brucellosis is a zoonosis with worldwide distribution, which is particularly endemic in many countries of the Mediterranean basin. Cardiovascular complications of this disease, such as endocarditis, myocarditis and pericarditis, are very rare, with even fewer cases of myocarditis or asymptomatic pericardial effusion in the absence of concomitant endocarditis being reported.

Case presentation

We report two cases of brucellosis in two Caucasian men, aged 17 and 34 years old, with myocarditis and asymptomatic pericardial effusion, respectively. Of note, neither patient had concomitant endocarditis. The disease was confirmed serologically and by blood cultures. Both patients recovered completely after receiving appropriate antibiotic treatment without any sign of relapse during a follow-up of 12 months.

Conclusion

These two cases emphasize that in endemic areas Brucella can be considered as a potentially causative agent of idiopathic pericardial effusion or myocarditis, even in the absence of concomitant endocarditis. This possibility could be taken into account particularly in cases where contraction of brucellosis is possible, such as occupational exposure or consumption of unpasteurized dairy products.

Introduction

Brucellosis is a worldwide zoonosis, with the Mediterranean basin, the Middle East, India, Mexico, and Central and South America being the most affected areas [1]. The disease has generalized and systemic symptoms, and almost every organ of the human body can be affected by Brucella. Despite this, the incidence of cardiovascular complications in brucellosis, such as endocarditis, myocarditis or pericarditis, is reported to be as low of 1% of cases [1, 2], with even fewer cases of myocarditis or pericarditis in the absence of concomitant endocarditis being reported. Indeed, myocarditis, pericarditis or asymptomatic pericardial effusion in brucellosis is thought to develop almost exclusively in the presence of endocarditis [1, 2]. We report two cases of patients, one with asymptomatic pericardial effusion and the other myocarditis caused by brucellosis in the absence of concomitant endocarditis. These unusual features of brucellosis may be underestimated components of the disease.

Case presentations

Patient 1

A 34-year-old Caucasian man was admitted our hospital with malaise, fatigue, and low-grade fever (up to 38°C), and a two-month history of rigors. He also reported anorexia and weight loss, night sweats, and generalized arthralgia. His medical history was non-contributory. He worked as a food handler.

On physical examination, the only abnormalities were a systolic murmur (grade II/VI) of the heart and hepatosplenomegaly. Laboratory investigations revealed low haemoglobin 11.6 g/dL (normal range 13.0-18.0 g/dL), and raised aspartate aminotransferase (57 U/L; upper normal limit (UNL) 40 U/L), alaninoaminotransferase (57 U/L; UNL: 40 U/L) and gamma-glutamyl transpeptidase (55 U/L; UNL 37 U/L). Electrocardiography (ECG) was normal with sinus rhythm, but chest radiography revealed slight cardiomegaly. Stool, urine and pharynx cultures, and investigations for Epstein-Barr virus (EBV), cytomegalovirus, enteric cytopathic human orphan (ECHO) virus, coxsackie viruses, herpes simplex virus (HSV), varicella-zoster virus (VSV), adenovirus, Coxiella burnetti, Chlamydia pneumoniae, Leptospira spp. and Mycoplasma pneumoniae were negative. However, serum agglutination tests were positive (titre >1:2560), and enzyme-linked immunosorbent assay (SERION ELISA Classic IgG/IgM; Institute Virion/Serion GmbH, Wurzburg, Germany) tests for anti-Brucella IgG and IgM antibodies were strongly positive (118 U/ml and 35.5 U/ml; UNL 30 U/ml and 20 U/ml, respectively). In addition, Brucella spp. were isolated from consecutive blood cultures (six out of eight cultures positive). Two-dimensional trans-thoracic and trans-oesophageal echocardiography was performed to investigate for the possible presence of Brucella-related endocarditis because of our patient's systolic heart murmur, six positive blood cultures and presence of cardiomegaly on chest radiographs. The investigation showed normal valves without any sign of vegetation; however, there was marked pericardial effusion without signs of cardiac tamponade, even though our patient had not reported any chest pain.

Additional extensive laboratory blood tests were performed because of the asymptomatic pericardial effusion, including tumor markers, C-reactive protein, fibrinogen, rheumatoid factor, antinuclear antibodies, anti-double-stranded DNA antibodies, serum immunoglobulins, and C3 and C4 component, but did not reveal the cause. There were no clinical or radiologic signs (computed tomography and MRI scans) suggestive for the presence of spondylitis, splenic disease or epididymoorchitis.

Accordingly, a diagnosis of Brucella-related asymptomatic pericardial effusion in the absence of concomitant endocarditis was made and specific treatment with antibiotics only was started immediately. Our patient was given oral doxycycline 100 mg twice daily plus oral rifampicin 900 mg once daily for three months, with intramuscular streptomycin 1 g once daily for the first three weeks. Our patient attended for treatment and follow-up to our outpatient clinic every two weeks. His symptoms regressed rapidly 10 days after initiation of treatment, and no recurrence or adverse drug reactions were observed during follow-up (to one year from the beginning of therapy). Echocardiographic studies three, six and 12 months after the start of treatment showed no pericardial effusion. When last seen, 12 months after starting therapy, our patient was well with no sign of relapse.

Patient 2

A 17-year-old Caucasian man was admitted to our hospital with a six-day history of high-grade fever (up to 39°C) and chest pain. He also reported fatigue, anorexia, generalized arthralgia, headache and night sweats. He had been treated with paracetamol by his general practitioner for an upper respiratory infection, but the symptoms remained and worsened. He was living in a rural area of central Greece and was working as a stock farmer. His medical history was unremarkable.

On physical examination, only tachypnoea and hepatosplenomegaly were seen. ECG demonstrated repolarization disturbances with T-wave inversion in the II, III, aVF and V2 to V6 leads.

Laboratory investigations found a raised white blood cell count of 11.15 x 109/l (normal range 4-11 x 109/L), creatine phosphokinase 305 IU/L (30-190 IU/L) and lactate dehydrogenase 247 IU/L (12-230 IU/L). Results of the remaining haematological and biochemical tests, including liver function tests, were within normal ranges. A qualitative determination of troponin was positive, which was confirmed by a quantitative method.

A diagnosis of myocarditis due to an infectious agent was suspected because of the history of chest pain in association with the positive troponin test and the ECG abnormalities. Two-dimensional trans-thoracic and trans-oesophageal echocardiography revealed a mild regional motion abnormality of the left ventricular wall but without pericardial effusion or valves vegetations. Blood, urine, and pharynx cultures were negative, as were serology tests for Influenza A and B, parvovirus, EBV, CMV, ECHO virus, coxsackie virus, HSV, VSV, adenovirus, Coxiella burnetti, Chlamydia pneumonia, Leptospira, Mycoplasma pneumonia. However, serum agglutination tests were positive at a titre >1:1280 and ELISA results for anti-Brucella IgG and IgM antibodies were strongly positive (92 U/ml and 48 U/ml, antibodies, respectively), and Brucella spp was isolated in two out of four sets of blood cultures. As for patient 1, there were no clinical and radiologic signs suggestive for the presence of other systemic features of the disease.

Accordingly, a diagnosis of Brucella-related myocarditis was made and our patient was treated only with the specific triple antibiotic regimen as for patient 1 (oral doxycycline 100 mg twice daily plus oral rifampicin 900 mg once daily for three months, with intramuscular streptomycin 1 g once daily for the first three weeks). His symptoms regressed rapidly after initiation of treatment. His echocardiographic and ECG studies three and 12 months after the start of treatment were completely normal, and he showed no signs of relapse during 12 months of follow-up at our outpatient clinic.

Discussion

Brucellosis is still highly prevalent in countries of the Mediterranean basin including Greece [1, 35]. Based on the well-known routes of transmission, brucellosis has long been considered an occupational disease affecting shepherds, abattoir workers, food handlers, veterinarians, dairy-industry professionals, and personnel in microbiologic laboratories [1, 46]. The clinical features of the disease include splenomegaly, joint involvement presenting as arthritis or spondylodiscitis, lymphadenopathy, lung or liver involvement, and orchitis or epididymoorchitis [1, 79].

Cardiovascular complications of brucellosis (endocarditis, myocarditis and pericarditis) are rare. In cases of endocarditis, which is the most common cardiovascular involvement of the disease, the aortic valve and less frequently the mitral valve are affected. No good response to medical therapy has been observed, and there is poor prognosis without surgery [10]. Replacement of the affected valve is almost always necessary after five to seven days of antibiotic therapy [10]. In these cases, the development of pericardial effusion or myocarditis is common. However, in the absence of concomitant Brucella-related endocarditis, development of pericardial effusion and/or myocarditis seems to be extremely rare [1, 2, 1118]. Indeed, when we searched in the MEDLINE database for articles published between 1984 and 2010 using the words 'pericarditis', 'myocarditis' and 'brucellosis', we identified only 11 reports in the English literature of adult patients with brucellosis including 14 patients with appropriate information for analysis on brucellosis-related pericarditis or myocarditis in the absence of concomitant endocarditis [2, 12, 14, 17, 1925] (Table 1). In addition, pericarditis or myocarditis was not reported in any recently reported cases (>200) of brucellosis [1, 13]. In another study from Spain (Malaga), it was reported that only 1.5% of 530 brucellosis cases had cardiac involvement, with only one patient with pericarditis and one with myocarditis (0.2%) in the absence of concomitant endocarditis (Table 1) [2]. In a prospective study of 400 cases from Kuwait, only two cases with endocarditis and an additional six cases of other cardiovascular complications (including one case of myocarditis) were reported (Table 1) [19]. Lubani et al.[26] reported three more cases of Brucella myocarditis in a series of 200 children with brucellosis, and myocarditis has also been described in a case of disseminated brucellosis with multiple organ involvement [20].
Table 1

Review of the clinical characteristics, treatment and outcome of the reported adult patients in the English literature with Brucellosis-related pericarditis and/or myocarditis in the absence of concomitant endocarditis.

Publication (Ref)

Cases, n

Clinical presentation

ECG

Echocardiography

Serum agglutination test

Cultures

Pericarditis

Myocarditis

Treatment

Outcome

Pandit et al., 2010 [21]

1

Fever, dyspnea, constitutional symptomsa

Sinus tachycardia

Abnormal

1:1280

Positive

No

Yes

Streptomycin, doxycycline

Death

Efe et al., 2009 [17]

1

Dyspnea

ST-depression T-wave inversion

Diffuse hypokinesia and ventricular dilatation (10-15% ejection fraction)

1:5120

Positive

No

Yes

Streptomycin (3 weeks, doxycycline (6 weeks

Cure

Khorvash et al., 2007 [20]

1

Fever, constitutional symptoms

Sinus bradycardia High T-waves

Septal hypokinesia, 30% ejection fraction

1:80

Positive

No

Yes

Doxycycline (6 weeks, rifampicin (6 weeks

Relapse

Hatipoglu et al., 2004 [14]

2

Dyspnea, arthritis, constitutional symptoms

NA

Pericardial effusion

1:320

Positive

Yes

No

Doxycycline (6 months), ofloxacin (6 months), rifampicin (6 months)

Cure

  

Fever, dyspnea, retrosternal pain

NA

Pericardial effusion

1:640

Negative

Yes

No

Gentamicin (2 weeks, doxycycline (6 weeks, ciprofloxacin (6 weeks

Cure

Karagiannis et al., 2003 [22]

1

Fever, dyspnea

Atrial fibrillation

Large pericardial effusion

1:1280

Negativeb

Yes

No

Streptomycin (2 weeks, doxycycline (6 weeks, indomethacin (2 weeks

Cure

Colmenero et al., 1996 [2]

2c

NA

NA

NA

NA

NA

Yes

Yes

Na

NA

Jubber et al., 1990 [23]

1d

Fever, dyspnea, constitutional symptoms

T-wave inversion

Moderate hypokinesia of interventricular septum and posterior wall of left ventricle

Negative

NA

No

Yes

Vibramycin, rifampicin

Cure

Rivera et al., 1988 [24]

1

Fever, chest pain, pericardial friction rub

NA

Moderate pericardial effusion

1:640

Positive

Yes

No

Rifampicin, doxycycline

Cure

Lulu et al., 1988 [19]

1e

NA

NA

NA

NA

NA

No

Yes

NA

NA

Ugartemendia et al., 1985 [12]

2

Fever, chest pain

NA

Severe pericardial effusion in both (tamponade)

1:320, 1:640

Positive

Yes

No

Cotrimoxazole, streptomysin, oxytetracycline

1 death, 1 cure

Gur et al., 1984 [25]

1

High remittent fever

Negative, biphasic or flat T-waves

NA

1:6400

Positive

No

Yes

Streptomycin (2 weeks, tetracycline (4.5 weeks

Relapse

aConstitutional symptoms include sweating, malaise, anorexia, weight loss, arthralgias, myalgias.

bThis patient was already receiving antibiotic treatment.

cTwo out of a series of 530 patients (one patient had pericarditis and one myocarditis).

dDiagnosis based on high titers of antibodies by ELISA.

eOne out of 400 cases of brucellosis.

NA = not available.

In our first patient, the general symptoms were predominant and, contrary to other reports [12, 14, 24], the pericardial effusion was asymptomatic. This suggests that this unusual feature could be underestimated if echocardiography is not in routine use. However, both patients showed evidence of cardiac involvement on routine tests (chest radiography in the first and ECG in the second case) making the value of routine use of echocardiography in suspected cases of brucellosis questionable.

The cardiac damage may be due to a direct effect of the microorganism as suggested by pericardial fluid cultures [12], or by local deposit of immunocomplexes as seen in cardiac biopsies. In this context, the role of delayed diagnosis, as in our first patient, in the development of cardiovascular complications of brucellosis may deserve further evaluation. The diagnosis is based on the demographic and epidemiologic characteristics of the disease, the presence of symptoms, results of serological tests, isolation of the microorganism by blood or bone marrow cultures, and exclusion of other possible causes of pericardial effusion and myocarditis. Pericardiocentesis and heart biopsy remain the techniques of choice for supporting a definite diagnosis of Brucella-related involvement of the heart, but these interventional investigations are not easily performed for diagnosis in routine clinical practice and add no additional information when a safe diagnosis has already been made by other means.

We treated both our patients with triple antibiotic therapy only (without non-steroidal anti-inflammatory drugs or prednisolone). The response was complete in both, with no signs of relapses during the follow-up period. Although endocarditis was not found, both patients received treatment for three months because we believe that cardiac involvement (even in the absence of endocarditis) along with repetitive positive blood cultures cannot be safely considered an uncomplicated form of the disease while we lack evidence-based data from large prospective studies on the treatment of cardiovascular features of this disease in the absence of concomitant endocarditis.

Conclusion

These cases further emphasize that Brucella can affect every organ and system of the human body [1, 8, 9, 27, 28]. The prevalence of involvement of the pericardium or myocardium in the absence of concomitant endocarditis in brucellosis may be underestimated because thorough echocardiographic studies in patients with brucellosis are lacking. However, both our patients showed evidence of cardiac involvement on routine tests and therefore, use of these tests seems to be essential in the assessment of febrile patients, especially where brucellosis is clinically and epidemiologically suspected. Echocardiography can be then used if such abnormalities are detected on routine tests. Nevertheless, we believe that in areas where the disease is endemic, it is reasonable to include brucellosis in the differential diagnosis of disorders that affect the pericardium or myocardium even in the absence of concomitant endocarditis, although large prospective echocardiographic studies in established brucellosis cases are needed in an attempt to definitively address the precise prevalence of cardiac complications of brucellosis. We are currently undertaking such studies.

Consent

Written informed consent was obtained from the patients for publication of these case reports. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Declarations

Authors’ Affiliations

(1)
Department of Medicine, Medical School, University of Thessaly
(2)
Second Department of Medicine, General Hospital of Larissa

References

  1. Pappas G, Akritidis N, Bosilkovski M, Tsianos E: Brucellosis. N Engl J Med. 2005, 352: 2325-36. 10.1056/NEJMra050570.View ArticlePubMedGoogle Scholar
  2. Colmenero JD, Reguera JM, Martos F: Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine (Baltimore). 1996, 75: 195-211.View ArticleGoogle Scholar
  3. Corbel MJ: Brucellosis: an overview. Emerg Infect Dis. 1997, 3: 213-21. 10.3201/eid0302.970219.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Tasbakan MI, Yamazhan T, Gokengin D: Brucellosis: a retrospective evaluation. Trop Doct. 2003, 33: 151-3.PubMedGoogle Scholar
  5. Refai M: Incidence and control of brucellosis in the Near East region. Vet Microbiol. 2002, 90: 81-110. 10.1016/S0378-1135(02)00248-1.View ArticlePubMedGoogle Scholar
  6. McDermott JJ, Arimi SM: Brucellosis in sub-Saharan Africa: epidemiology, control and impact. Vet Microbiol. 2002, 90: 111-34. 10.1016/S0378-1135(02)00249-3.View ArticlePubMedGoogle Scholar
  7. Kapsalaki E, Gatselis N, Stefos A, Makaritsis K, Vassiou A, Fezoulidis I, Dalekos GN: Spontaneous spondylodiscitis: presentation, risk factors, diagnosis, management, and outcome. Int J Infect Dis. 2009, 13: 564-9. 10.1016/j.ijid.2008.08.025.View ArticlePubMedGoogle Scholar
  8. Zachou K, Papamichalis PA, Dalekos GN: Severe pharyngitis in stockbreeders: an unusual presentation of brucellosis. Occup Med (Lond). 2008, 58: 305-7. 10.1093/occmed/kqn020.View ArticleGoogle Scholar
  9. Bourantas KL, Christou LG, Dalekos GN, Barbati K, Tsianos EV: A 54-year-old stockbreeder with ascites. Lancet. 1997, 349: 994-10.1016/S0140-6736(96)11090-4.View ArticlePubMedGoogle Scholar
  10. Kula S, Erer D, Buyukates M, Tunaoglu FS, Olgunturk R, Ozdogan EM: Brucella endocarditis: case report and review of the literature. J Heart Valve Dis. 2001, 10: 486-8.PubMedGoogle Scholar
  11. Gomez-Huelgas R, de Mora M, Porras JJ, Nuno E, SanRoman CM: Brucella and acute pericarditis: fortuitous or causal association?. J Infect Dis. 1986, 154: 544-View ArticlePubMedGoogle Scholar
  12. Ugartemendia MC, Curos-Abadal A, Pujol-Rakosnik M, Pujadas-Capmany R, Escriva-Montserrat E, Jane-Pesquer J: Brucella melitensis pericarditis. Am Heart J. 1985, 109: 1108-10.1016/0002-8703(85)90258-3.View ArticlePubMedGoogle Scholar
  13. Colmenero JD, Porras JJ, Valdivielso P: [Brucellosis: a prospective study of 100 cases] (in Spanish). Med Clin (Barc). 1986, 86: 43-8.Google Scholar
  14. Hatipoglu CA, Yetkin A, Ertem GT, Tulek N: Unusual clinical presentations of brucellosis. Scand J Infect Dis. 2004, 36: 694-7.PubMedGoogle Scholar
  15. Garcia de Lucas MD, Castillo Dominquez JC, Martinez Gonzalez MS: Brucella myopericarditis. Rev Esp Cardiol. 2004, 57: 709-10.1157/13064200.View ArticlePubMedGoogle Scholar
  16. Marcos Sanchez F, Vazquez Garcia A, Juarez Ucelay F, Lopez Onega P, Duran Perez-Navarro A: Myocardial and pericardial symptoms as a presentation of brucellosis. Ann Med Interna. 1991, 8: 100-1.Google Scholar
  17. Efe C, Can T, Ince M, Tunca H, Yildiz F, Sennaroglu E: A rare complication of Brucella infection: myocarditis and heart failure. Intern Med. 2009, 48: 1773-4. 10.2169/internalmedicine.48.2385.View ArticlePubMedGoogle Scholar
  18. Villaverde M, Gurini L, Gonzalez A, Cohen R: Febrile syndrome: myocarditis and brucellosis. Medicina (B Aires). 1995, 55: 145-6.Google Scholar
  19. Lulu AR, Araj GF, Khateeb MI, Mustafa MY, Yusuf AR, Fenech FF: Human Brucellosis in Kuwait: a prospective study of 400 cases. Q J Med. 1988, 66: 39-54.PubMedGoogle Scholar
  20. Khorvash F, Keshteli AH, Behjati M, Salehi M, Emami Naeini A: An unusual presentation of brucellosis, involving multiple organ systems, with low agglutinating titers: a case report. J Med Case Reports. 2007, 1: 53-10.1186/1752-1947-1-53.View ArticlePubMed CentralGoogle Scholar
  21. Pandit VR, Seshadri S, Valsalan R, Bahuleyan S, Vandana KE, Kori P: Acute brucellosis complicated by fatal myocarditis. Int J Infect Dis. 2010, 14: e358-360. 10.1016/j.ijid.2009.05.013.View ArticlePubMedGoogle Scholar
  22. Karagiannis S, Mavrogiannaki A, Chrissos D, Papatheodoridis G: Cardiac tambonade in Brucella infection. Hell J Cardiol. 2003, 44: 222-225.Google Scholar
  23. Jubber AS, Gunawardana DR, Lulu AR: Acute pulmonary edema in Brucella myocarditis and interstitial pneumonitis. Chest. 1990, 97: 1008-1009. 10.1378/chest.97.4.1008.View ArticlePubMedGoogle Scholar
  24. Rivera JM, Garcia-Bragado F, Gomez FA, Grilo A, Lozano-Gutierrez F: Brucellar pericarditis. Infection. 1988, 16: 254-10.1007/BF01650771.View ArticlePubMedGoogle Scholar
  25. Gur H, Gefel R, Tur-Kapsa : Transient electrocardiographic changes during two episodes of relapsing brucellosis. Postgrad Med J. 1984, 60: 544-545. 10.1136/pgmj.60.706.544.View ArticlePubMedPubMed CentralGoogle Scholar
  26. Lubani M, Sharda D, Helin I: Cardiac manifestations in brucellosis. Arch Dis Child. 1986, 61: 569-72. 10.1136/adc.61.6.569.View ArticlePubMedPubMed CentralGoogle Scholar
  27. Andriopoulos P, Tsironi M, Asimakopoulos G: Acute abdomen due to Brucella melitensis. Scand J Infect Dis. 2003, 35: 204-5. 10.1080/0036554021000027025.View ArticlePubMedGoogle Scholar
  28. Tsironi M, Andriopoulos P, Kalkani M, Asimakopoulos G: Human mammary abscess caused by Brucella melitensis: a case report. Int J Infect Dis. 2003, 7: 236-10.1016/S1201-9712(03)90061-0.View ArticlePubMedGoogle Scholar

Copyright

© Gatselis et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement